Global Post-Traumatic Stress Disorder (PTSD) Market is expected to cross USD 7.3 Billion by 2025 at a CAGR of 4.8%. - PowerPoint PPT Presentation

About This Presentation
Title:

Global Post-Traumatic Stress Disorder (PTSD) Market is expected to cross USD 7.3 Billion by 2025 at a CAGR of 4.8%.

Description:

According to MRFR analysis, the global Post-Traumatic Stress Disorder (Ptsd) Market is expected to register a CAGR of 4.8% during the forecast period of 2019 to 2025 and was valued at USD 7.3 billion in 2018. – PowerPoint PPT presentation

Number of Views:69

less

Transcript and Presenter's Notes

Title: Global Post-Traumatic Stress Disorder (PTSD) Market is expected to cross USD 7.3 Billion by 2025 at a CAGR of 4.8%.


1
Global Post-Traumatic Stress Disorder (PTSD)
Market is expected to cross USD 7.3 Billion by
2025 at a CAGR of 4.8.
SAMPLE
FOR MORE INFO
2
Post-Traumatic Stress Disorder (PTSD) Market
Market Highlights According to MRFR analysis,
the global Post-Traumatic Stress Disorder (Ptsd)
Market is expected to register a CAGR of 4.8
during the forecast period of 2019 to 2025 and
was valued at USD 7.3 billion in 2018.
Post-Traumatic Stress Disorder (PTSD) develops
when a person is exposed to a traumatic event
such as warfare, violent sexual assault, or other
severe threats on a persons life. A person with
PTSD is at a higher risk for suicide and
intentional self-harm. Children under the age of
10 are less likely to develop PTSD than adults.
Prevention is possible when therapy is targeted
at those with early symptoms but is not valid
when carried out among all people following
trauma. The chief treatments for people with PTSD
are counseling and medication. The global
post-traumatic stress disorder (PTSD) market is
currently dominated by several market players.
The key players are involved in product launches
and strategic collaborations to strengthen their
market positions. Request For Free Sample
Report https//www.marketresearchfuture.com/sampl
e_request/8376
3
Post-Traumatic Stress Disorder (PTSD) Market
Segmentation The global post-traumatic stress
disorder (PTSD) market has been segmented based
on treatment and end user. The market, based on
treatment, has been divided into psychotherapy
and medication. The psychotherapy has been
further segmented into cognitive therapy,
exposure therapy, and eye movement
desensitization and reprocessing (EMDR). The
medication has been segmented into
antidepressants, anti-anxiety medications, and
prazosin. The antidepressants are classified as
paroxetine, sertraline, mirtazapine, and
amitriptyline, or phenelzine. The anti-anxiety
drugs have been classified as beta-blockers and
benzodiazepines. The medication segment is
expected to hold the largest segment during the
forecasted period. The end user segment of the
market are hospitals and clinics, ambulatory
surgical centers, and others. The hospitals and
clinics segment is expected to hold the largest
share of the market as these centers are the
primary locations for patients receiving
treatment and surgery. Access Report Details _at_
https//www.marketresearchfuture.com/reports/post-
traumatic-stress-disorder-market-8376
4
Post-Traumatic Stress Disorder (PTSD) Market
Regional Analysis The market has been divided, by
region, into the Americas, Europe, Asia-Pacific,
and the Middle East Africa. The Americas is
expected to be the largest market owing to the
increasing prevalence of PTSD and rising per
capita healthcare expenditure. The post-traumatic
stress disorder (PTSD) market in the Americas has
further been branched into North America and
Latin America, with the North American market
divided into the US and Canada. The European
post-traumatic stress disorder (PTSD) market has
been categorized as Western Europe and Eastern
Europe. The Western European market has further
been classified as Germany, France, the UK,
Italy, Spain, and the rest of Western Europe. The
post-traumatic stress disorder (PTSD) market in
Asia-Pacific has been segmented into Japan,
China, India, South Korea, Australia, and the
rest of Asia-Pacific. The Asia Pacific region is
the fastest region due to the increasing cases of
sexual assault and road accidents and raising
awareness about the treatment methods. The
post-traumatic stress disorder (PTSD) market in
the Middle East Africa has been divided into
the Middle East and Africa. Key Players Some of
the key players in the global post-traumatic
stress disorder (PTSD) market are Azevan
Pharmaceuticals (US), Marinus Pharmaceuticals,
Inc. (US), Bionomics (Australia), Greenstone LLC
(US), GlaxoSmithKline (UK), Pfizer (US), Eli
Lilly and Company (US), H. Lundbeck A/S
(Denmark), Tonix Pharmaceuticals Holding Corp.
(US), and Mylan NV (US).
5
ABOUT US
MARKET RESEARCH FUTURE At Market Research Future
(MRFR), we enable our customers to unravel the
complexity of various industries through our
Cooked Research Report (CRR), Half-Cooked
Research Reports (HCRR), Raw Research Reports
(3R), Continuous-Feed Research (CFR), and Market
Research Consulting Services. MRFR team have
supreme objective to provide the optimum quality
market research and intelligence services to our
clients. Our market research studies by products,
services, technologies, applications, end users,
and market players for global, regional, and
country level market segments, enable our clients
to see more, know more, and do more, which help
to answer all their most important questions. In
order to stay updated with technology and work
process of the industry, MRFR often plans
conducts meet with the industry experts and
industrial visits for its research analyst
members. For more information kindly visit
www.marketresearchfuture.com or contact us at
info_at_marketresearchfuture.com Copyright 2018
Market Research Future All Rights Reserved. This
document contains highly confidential information
and is the sole property of Market Research
Future. No part of it may be circulated, copied,
quoted, or otherwise reproduced without the
written approval of Market Research Future.
6
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com